Featuring proceedings from a live event on January 9, 2026, held adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium and moderated by Dr Samuel J Klempner, including the following topics:
- Treatment approach for metastatic HER2-negative, claudin 18.2-positive, microsatellite instability-high gastroesophageal (GE) cancer (0:00)
- Duration of chemotherapy for patients with advanced GE cancers receiving nivolumab/chemotherapy (3:06)
- Younger patient with metastatic PD-L1-positive gastric cancer (5:29)